Virtual Screening-Based Study of Novel Anti-Cancer Drugs Targeting G-Quadruplex
Pharmaceutics · 05.05.2023 · 15 (5) · 1414
DOI: 10.3390/pharmaceutics15051414 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 05.05.2023. Verfasst von Ruizhuo Ouyang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai 200093, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanghai, Clinical research project of Shanghai Municipal Health Commission, Scientific research program of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
In order to develop new anti-cancer drugs more efficiently and reduce side effects based on active drug targets, the virtual drug screening was carried out through the target of G-quadruplexes and 23 hit compounds were, thus, screened out as potential anticancer drugs. Six classical G-quadruplex complexes were introduced as query molecules, and the three-dimensional similarity of molecules was calculated by shape feature similarity (SHAFTS) method so as to reduce the range of potential compounds. Afterwards, the molecular docking technology was utilized to perform the final screening followed by the exploration of the binding between each compound and four different structures of G-quadruplex. In order to verify the anticancer activity of the selected compounds, compounds 1, 6 and 7 were chosen to treat A549 cells in vitro, the lung cancer epithelial cells, for further exploring their anticancer activity. These three compounds were found to be of good characteristics in the treatment of cancer, which revealed the great application prospect of the virtual screening method in developing new drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Bismuth and Rhenium Science, University of Shanghai for Science and Technology, Shanghai 200093, China.
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
- Cancer Institute, Tongji University School of Medicine, Shanghai 200092, China.
ORCID-Profile: Ruizhuo Ouyang, Shen Wang
Förderung
- Natural Science Foundation of Shanghai
- Clinical research project of Shanghai Municipal Health Commission
- Scientific research program of Shanghai Science and Technology Commission
- Shanghai Collaborative Innovation Center of Energy Therapy for Tumors, Clinical research project of Shanghai Municipal Health Commission
Zitieren
APA
Ouyang, R., Liu, J., Wang, S., Zhang, W., Feng, K., Liu, C., Liu, B., Miao, Y., & Zhou, S. (2023). Virtual Screening-Based Study of Novel Anti-Cancer Drugs Targeting G-Quadruplex. Pharmaceutics, 15(5), 1414. https://doi.org/10.3390/pharmaceutics15051414
Vancouver
Ouyang R, Liu J, Wang S, Zhang W, Feng K, Liu C, et al. Virtual Screening-Based Study of Novel Anti-Cancer Drugs Targeting G-Quadruplex. Pharmaceutics. 2023;15(5):1414. doi:10.3390/pharmaceutics15051414
BibTeX
@article{Ouyang2023,
author = {Ouyang, Ruizhuo and Liu, Jinyao and Wang, Shen and Zhang, Weilun and Feng, Kai and Liu, Conghao and Liu, Baolin and Miao, Yuqing and Zhou, Shuang},
title = {Virtual Screening-Based Study of Novel Anti-Cancer Drugs Targeting G-Quadruplex},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {5},
pages = {1414},
doi = {10.3390/pharmaceutics15051414}
}
EUVIMED